Loading publications…
The last 5 uploaded publications
Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma
Daniela Sia, Bojan Losic, Agrin Moeini, Laia Cabellos, Ke Hao, Kate Revill, Dennis M. Bonal, Oriana Miltiadous, Zhongyang Zhang, Yujin Hoshida, Helena Cornellà, Mireia Castillo-Martín, Roser Pinyol, Yumi Kasai, Sasan Roayaie, Swan N. Thung, Josep Fuster, Myron Schwartz, Samuel Waxman, Carlos Cordon‐Cardo, Eric E. Schadt, Vincenzo Mazzaferro, Josep M. Llovet (2015). Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma. Nature Communications, 6(1), DOI: 10.1038/ncomms7087.
Article145 days agoMolecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
Roser Pinyol, Robert Montal, Laia Bassaganyas, Daniela Sia, Tadatoshi Takayama, Gar-Yang Chau, Vincenzo Mazzaferro, Sasan Roayaie, Han Chu Lee, Norihiro Kokudo, Zhongyang Zhang, Sara Torrecilla, Agrin Moeini, Leonardo Rodríguez‐Carunchio, Edward Gane, Chris Verslype, Adina Croitoru, Umberto Cillo, Manuel de la Mata, L. Lupo, Simone I. Strasser, Joong‐Won Park, Jordi Camps, Manel Solé, Swan N. Thung, Augusto Villanueva, Carol Peña, Gerold Meinhardt, Jordi Bruix, Josep M. Llovet (2018). Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial. Gut, 68(6), pp. 1065-1075, DOI: 10.1136/gutjnl-2018-316408.
Article145 days agoMolecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
Robert Montal, Daniela Sia, Carla Montironi, Wei Qiang Leow, Roger Esteban-Fabró, Roser Pinyol, Miguel Torres‐Martín, Laia Bassaganyas, Agrin Moeini, Judit Peix, Laia Cabellos, Miho Maeda, Carlos Villacorta-Martín, Parissa Tabrizian, Leonardo Rodríguez‐Carunchio, Giancarlo Castellano, Christine Sempoux, Beatriz Mínguez, Timothy M. Pawlik, Ismaïl Labgaa, Lewis R. Roberts, Manel Solé, Maria Isabel Fiel, Swan N. Thung, Josep Fuster, Sasan Roayaie, Augusto Villanueva, M. Schwartz, Josep M. Llovet (2020). Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma. Journal of Hepatology, 73(2), pp. 315-327, DOI: 10.1016/j.jhep.2020.03.008.
Article145 days agoMolecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma
Agrin Moeini, Daniela Sia, Nabeel Bardeesy, Vincenzo Mazzaferro, Josep M. Llovet (2015). Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma. Clinical Cancer Research, 22(2), pp. 291-300, DOI: 10.1158/1078-0432.ccr-14-3296.
Article145 days agoIntrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
Daniela Sia, Victoria Tovar, Agrin Moeini, Josep M. Llovet (2013). Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies. Oncogene, 32(41), pp. 4861-4870, DOI: 10.1038/onc.2012.617.
Article145 days ago